|
MechanismGnRHR antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date08 Jan 2019 |
100 Clinical Results associated with Nuoqiao Pharmaceutical (Chengdu) Co., Ltd.
0 Patents (Medical) associated with Nuoqiao Pharmaceutical (Chengdu) Co., Ltd.
100 Deals associated with Nuoqiao Pharmaceutical (Chengdu) Co., Ltd.
100 Translational Medicine associated with Nuoqiao Pharmaceutical (Chengdu) Co., Ltd.